Item 2.02 Results of Operations and Financial Condition.
On
The foregoing information constitutes unaudited and preliminary estimates that
(i) represent the most current information available to management as of the
date of the presentation, (ii) are subject to completion of financial closing
and procedures that could result in significant changes to the estimated
amounts, and (iii) do not present all information necessary for an understanding
of the Company's financial condition as of, and its results of operations for
the year ended,
The information set forth in this Item 2.02 is being furnished pursuant to Item 2.02 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and it shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or under the Exchange Act, whether made before or after the date hereof, except as expressly provided by specific reference in such a filing.
Item 7.01. Regulation FD Disclosure.
Beginning on
The information set forth in and incorporated by reference into this Item 7.01
is being furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed
"filed" for purposes of Section 18 of the Exchange Act or otherwise subject to
the liabilities of that section, and it shall not be deemed incorporated by
reference in any filing under the Securities Act or under the Exchange Act,
whether made before or after the date hereof, except as expressly provided by
specific reference in such a filing. By filing this Current Report on Form 8-K
and furnishing the information in and incorporated by reference into this Item
7.01, the Company makes no admission as to the materiality of Item 7.01 in this
report or the presentations available on the Company's website. The information
contained in the presentations is summary information that is intended to be
considered in the context of the Company's filings with the
Forward-Looking Statements
This report and the presentations may contain forward-looking statements within
the meaning of Section 27A of the Securities Act and Section 21E of the Exchange
Act. Our forward-looking statements are based on current beliefs and
expectations of our management team that involve risks, potential changes in
circumstances, assumptions, and uncertainties, including statements about the
anticipated timing of release of topline results of our clinical trials; the
progression of our discovery programs into clinical development; and the
business and operations of the Company. We may, in some cases use terms such as
"predicts," "believes," "potential," "continue," "anticipates," "estimates,"
"expects," "plans," "intends," "may," "could," "might," "likely," "will,"
"should" or other words that convey uncertainty of the future events or outcomes
to identify these forward-looking statements. Each forward-looking statement is
subject to risks and uncertainties that could cause actual results to differ
materially from those expressed or implied in such statement. Applicable risks
and uncertainties include those related to the possibility that any results of
operations and financial condition of the Company reported are preliminary and
subject to final audit and the risks listed under the heading "Risk Factors" and
elsewhere in our 2019 Form 10-K filed on
2
--------------------------------------------------------------------------------
reliance on these forward-looking statements. These forward-looking statements (except as otherwise noted) speak only as of the date of this report, and the Company undertakes no obligation to update these forward-looking statements, except as required by law.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description 99.1 Corporate Update Presentation datedJanuary 13, 2021 3
--------------------------------------------------------------------------------
© Edgar Online, source